RecruitingNCT05328050
Registry for Patients With Achondroplasia / Hypochondroplasia (OMPR-Ach/Hy)
Local Registry for Data Collection of Patients With Achondroplasia / Hypochondroplasia for Epidemiological, Care and Research Studies
Sponsor
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Enrollment
200 participants
Start Date
Sep 1, 2021
Study Type
OBSERVATIONAL
Conditions
Summary
This registry is a observational, single-center study designed to collect clinical data on patients with achondroplasia and hypochondroplasia.
Eligibility
Inclusion Criteria2
- Confirmed diagnosis of achondroplasia/hypochondroplasia
- Patients (and/or Parents legal guardian when required) able to provide informed consent
Exclusion Criteria2
- Absence of diagnosis of achondroplasia/hypochondroplasia
- Patients (and/or Parents legal guardian when required) not able to provide informed consent
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERRegistry
observational, data collection
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05328050
Related Trials
A Study of TYRA-300 in Children With Achondroplasia: BEACH301
NCT0684235515 locations
A Clinical Trial to Evaluate Efficacy and Safety of Navepegritide in Adolescents (12 - 18 Years of Age) With Achondroplasia.
NCT067328955 locations
Study to Evaluate the Efficacy and Safety of BMN 333 Versus Vosoritide in Children With Achondroplasia
NCT074418762 locations
A Clinical Trial to Evaluate Efficacy and Safety of TransCon CNP Compared With Placebo in Infants (0 to <2 Years of Age) With Achondroplasia
NCT0607939818 locations
Interventional Study of Infigratinib in Children < 3 Years Old With Achondroplasia (ACH)
NCT0716927913 locations